Search Results - "Torregrosa, Cécile"
-
1
Physical Activity as the Best Supportive Care in Cancer: The Clinician’s and the Researcher’s Perspectives
Published in Cancers (01-11-2022)“…Multidisciplinary supportive care, integrating the dimensions of exercise alongside oncological treatments, is now regarded as a new paradigm to improve…”
Get full text
Journal Article -
2
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX‐bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study
Published in International journal of cancer (01-12-2022)“…After failure of first line FOLFOX‐bevacizumab for metastatic colorectal cancer (mCRC), adding either bevacizumab or aflibercept to second‐line FOLFIRI…”
Get full text
Journal Article -
3
From incidentaloma to secondary discovery
Published in M.S. Médecine sciences (05-11-2020)“…The term incidentaloma, created in 1982, has spread throughout medical literature. However, there does not seem to be a precise definition to describe what an…”
Get more information
Journal Article -
4
A case of 8p11 syndrome associated with acute erythroblastic leukemia and T-lymphoblastic lymphoma treated with ponatinib combination and chemotherapy
Published in Hématologie (01-03-2017)Get full text
Journal Article -
5
La toxicité cardiaque des fluoropyrimidines : 5-fluorouracile, capécitabine, le composé S-1 et le trifluridine/tipiracil
Published in Bulletin du cancer (01-07-2018)“…L’incidence de la cardiotoxicité du 5-fluororouracile (5-FU) intraveineux et de la capécitabine varie dans la littérature de 1,2 à 18 %. La physiopathologie de…”
Get full text
Journal Article -
6
Place de la notion de guérison du cancer à l’heure de la médecine personnalisée et de l’immunothérapie
Published in Bulletin du cancer (01-03-2018)Get full text
Journal Article -
7
Pouvons-nous à l’heure actuelle parler de guérison après le traitement d’un cancer du sein localisé ?
Published in Bulletin du cancer (01-03-2018)“…Malgré les progrès thérapeutiques permanents en cancérologie, l’emploi du terme de guérison vis-à-vis des patients reste controversé, celui de rémission étant…”
Get full text
Journal Article